Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review

BACKGROUND: Convalescent plasma and hyperimmune immunoglobulin may reduce mortality in patients with viral respiratory diseases, and are currently being investigated in trials as potential therapy for coronavirus disease 2019 (COVID‐19). A thorough understanding of the current body of evidence regar...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Piechotta, Vanessa, Chai, Khai Li, Valk, Sarah J, Doree, Carolyn, Monsef, Ina, Wood, Erica M, Lamikanra, Abigail, Kimber, Catherine, McQuilten, Zoe, So-Osman, Cynthia, Estcourt, Lise J, Skoetz, Nicole
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2020
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7389743/
https://ncbi.nlm.nih.gov/pubmed/32648959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013600.pub2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky